Clopidogrel Response in Acute Ischemic Stroke
NCT01846572 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 159
Last updated 2013-05-03
Summary
The aim of this study was to determine the prevalence rate and risk factors for chemical laboratory clopidogrel low-response (CLR) in the acute phase after an ischemic stroke.
Conditions
Sponsors & Collaborators
-
Ruhr University of Bochum
lead OTHER
Principal Investigators
-
Saskia H Meves, MD · Ruhr University Bochum, Department of Neurology
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-07-31
- Primary Completion
- 2012-12-31
- Completion
- 2012-12-31
More Related Trials
-
Evaluation of the Efficacy of Novel Biomarkers in Predicting Clopidogrel Resistance in Patients with Ischemic Stroke
NCT06753149 ·Status: NOT_YET_RECRUITING
-
Clopidogrel Response and CYP2C19 Genotype in Ischemic Stroke Patients
NCT03385538 ·Status: COMPLETED ·Phase: PHASE4
-
Biomarkers of Clopidogrel Resistance for Predicting Ischemic Recurrence After Cerebral Artery Stenting
NCT07028775 ·Status: NOT_YET_RECRUITING
-
Aspirin and Clopidogrel Reactivity in Patients With Critical Limb Ischemia (CLI)
NCT02094755 ·Status: COMPLETED
-
Clopidogrel Preventive Effect Based on CYP2C19 Genotype in Ischemic Stroke
NCT04072705 ·Status: COMPLETED
-
Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)
NCT00050817 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Clopidogrel Loading and Risk of PCI
NCT00457236 ·Status: UNKNOWN
-
Ticagrelor Versus Clopidogrel in Carotid Artery Stenting
NCT02677545 ·Status: COMPLETED ·Phase: PHASE2
-
CIPAMI-Study: Clopidogrel Administered Prehospital to Improve Primary PCI in Patients With Acute Myocardial Infarction
NCT00372216 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Triflusal and Clopidogrel in Secondary Prevention of Stroke Based on the Genotyping
NCT01174693 ·Status: COMPLETED ·Phase: PHASE4
-
Clopidogrel Efficacy and Acute Coronary Syndromes
NCT00839267 ·Status: COMPLETED
-
Ticagrelor Versus Clopidogrel in Ischemic Stroke
NCT05553613 ·Status: COMPLETED ·Phase: PHASE3
-
Optimal Regimen in Endovascular Therapy in Ischemic Cerebrovascular Disease Based on Clopidogrel Resistance
NCT01925872 ·Status: UNKNOWN
-
Incidence of Major Cardiovascular Events in Diabetic Patients With ACS Undergoing Coronary Angioplasty and Treated With Clopidogrel 150 mg Versus 75 mg
NCT03329261 ·Status: COMPLETED ·Phase: PHASE4
-
75 or 150 mg Clopidogrel Maintenance Doses Following PCI (ISAR-CHOICE-2)
NCT00140465 ·Status: COMPLETED ·Phase: PHASE4
-
Half-dose Ticagrelor Overcomes High-dose Clopidogrel in Acute Coronary Syndrome Patients With High On-Clopidogrel Platelet Reactivity
NCT03062462 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3A
NCT00004564 ·Status: UNKNOWN ·Phase: NA
-
Effects of Intensive Antiplatelet Therapy for Patients With Clopidogrel Resistance After Coronary Stent Implantation
NCT01094457 ·Status: COMPLETED ·Phase: PHASE4
-
Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke
NCT06360120 ·Status: RECRUITING ·Phase: PHASE3
-
Investigation of the Athero-Protective Effects of Clopidogrel
NCT01283282 ·Status: COMPLETED ·Phase: PHASE4
-
Clopidogrel Resistance and the Possibility of Its Affection
NCT00839345 ·Status: TEMPORARILY_NOT_AVAILABLE
-
The Effect of Clopidogrel on Coated-Platelets in Patients Undergoing Cardiac Catheterization
NCT00644657 ·Status: COMPLETED ·Phase: NA
-
Genotype Guided Antiplatelet Therapy In Ischemic Stroke
NCT05763862 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
REsistance to Aspirin and Clopidogrel in acuTe Myocardial Infarction
NCT01381185 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Effect & Safety of Clopidogrel Napadisilate With Clopidogrel Bisulfate in Coronary Artery Disease Patients
NCT01830491 ·Status: COMPLETED ·Phase: PHASE4